P
Peter W. Adams
Researcher at University of Pittsburgh
Publications - 8
Citations - 680
Peter W. Adams is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Randomized controlled trial & Resuscitation. The author has an hindex of 5, co-authored 7 publications receiving 414 citations.
Papers
More filters
Journal ArticleDOI
Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock.
Jason L. Sperry,Francis X. Guyette,Joshua B. Brown,Mark H. Yazer,Darrell J. Triulzi,Barbara J. Early-Young,Peter W. Adams,Brian J. Daley,Richard S. Miller,Brian G. Harbrecht,Jeffrey A. Claridge,Herb A. Phelan,William R. Witham,A. Tyler Putnam,Therese M. Duane,Louis H. Alarcon,Clifton W. Callaway,Brian S. Zuckerbraun,Matthew D. Neal,Matthew R. Rosengart,Raquel M. Forsythe,Timothy R. Billiar,Donald M. Yealy,Andrew B. Peitzman,Mazen S. Zenati +24 more
TL;DR: In injured patients at risk for hemorrhagic shock, the prehospital administration of thawed plasma was safe and resulted in lower 30‐day mortality and a lower median prothrombin‐time ratio than standard‐care resuscitation.
Journal ArticleDOI
Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical Trial
Francis X. Guyette,Joshua B. Brown,Mazen S. Zenati,Barbara J. Early-Young,Peter W. Adams,Brian J. Eastridge,Raminder Nirula,Gary Vercruysse,Terence O'Keeffe,Bellal Joseph,Louis H. Alarcon,Clifton W. Callaway,Brian S. Zuckerbraun,Matthew D. Neal,Raquel M. Forsythe,Matthew R. Rosengart,Timothy R. Billiar,Donald M. Yealy,Andrew B. Peitzman,Jason L. Sperry +19 more
TL;DR: Prespecified dosing regimens and post-hoc subgroup analyses found that prehospital tranexamic acid were associated with significantly lower 30-day mortality, which is safe and associated with survival benefit in specific subgroups of patients.
Journal ArticleDOI
Taking the Blood Bank to the Field: The Design and Rationale of the Prehospital Air Medical Plasma (PAMPer) Trial
Joshua B. Brown,Francis X. Guyette,Matthew D. Neal,Jeffrey A. Claridge,Brian J. Daley,Brian G. Harbrecht,Richard S. Miller,Herb A. Phelan,Peter W. Adams,Barbara J. Early,Andrew B. Peitzman,Timothy R. Billiar,Jason L. Sperry +12 more
TL;DR: The rationale, design, and challenges of the Prehospital Air Medical Plasma (PAMPer) trial are described, one of three ongoing Department of Defense-funded trials aimed at expanding the understanding of the optimal therapeutic approaches to coagulopathy in the hemorrhaging trauma patient.
Journal ArticleDOI
Prehospital Plasma during Air Medical Transport in Trauma Patients.
Journal ArticleDOI
Implementation of a prehospital air medical thawed plasma program: Is it even feasible?
Peter W. Adams,Kayla A Warren,Frank X Guyette,Mark H Yazer,Joshua B. Brown,Brian J Daily,Richard S Miller,B. G. Harbrecht,Jeffrey A. Claridge,Herb A. Phelan,William R. Witham,A. Tyler Putnam,Brian S. Zuckerbraun,Matthew D. Neal,Jason L. Sperry +14 more
TL;DR: A prehospital plasma program utilizing thawed plasma is resource intensive but waste can be minimized depending on trauma center and blood bank specific logistics and implementation of aThawed plasma program can occur with financial cost.